Search results for “site:nih.gov”

Page 12 of about 453 results

ncbi.nlm.nih.gov pubmed › 33570583

Nutritional perspectives for the prevention and mitigation of COVID-19

Worldwide, there is an array of clinical trials under way to evaluate treatment options against coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2. Concurrently, several nutritional therapies...

ncbi.nlm.nih.gov pubmed › 33582134

Hydrating the respiratory tract: An alternative explanation why masks lower severity of COVID-19

The seasonality of respiratory diseases has been linked, among other factors, to low outdoor absolute humidity and low indoor relative humidity, which increase evaporation of water in the mucosal lining of the respiratory tract. We...

ncbi.nlm.nih.gov pubmed › 33737160

Cancer management during the COVID-19 pandemic: Choosing between the devil and the deep blue sea

COVID-19 was declared a "Public Health Emergency of International Concern" in March 2020. Since then, drastic measures were implemented to reduce the virus spread. These measures prevented cancer patients from receiving prompt medical...

ncbi.nlm.nih.gov pubmed › 33737894

Neuropsychiatric and Cognitive Sequelae of COVID-19

Coronavirus disease 2019 (COVID-19) is likely to have long-term mental health effects on individuals who have recovered from COVID-19. Rightly, there is a global response for recognition and planning on how to deal with mental health...

ncbi.nlm.nih.gov pubmed › 33777332

SARS-CoV-2 infection and smoking: What is the association? A brief review

Susceptibility to severe illness from COVID-19 is anticipated to be associated with cigarette smoking as it aggravates the risk of cardiovascular and respiratory illness, including infections. This is particularly important with the advent...

ncbi.nlm.nih.gov pubmed › 33834497

Salivary glands are a target for SARS-CoV-2: a source for saliva contamination

The ability of the new coronavirus SARS-CoV-2 to spread and contaminate is one of the determinants of the COVID-19 pandemic status. SARS-CoV-2 has been detected in saliva consistently, with similar sensitivity to that observed in...

ncbi.nlm.nih.gov pubmed › 34033370

Postacute Coronavirus (COVID-19) Syndrome

Coronavirus disease 2019 (COVID-19), the viral illness caused by the novel coronavirus SARS-CoV-2, has resulted in significant morbidity and mortality worldwide following the identification of the first cases in Wuhan, China, in December...

ncbi.nlm.nih.gov pubmed › 34037382

Developing a Paper-Based Antigen Assay to Differentiate between Coronaviruses and SARS-CoV-2 Spike Variants

COVID-19 first appeared in December of 2019 in Wuhan, China. Since then, it has become a global pandemic. A robust and scalable diagnostics strategy is crucial for containing and monitoring the pandemic. RT-PCR is a known, reliable method...

ncbi.nlm.nih.gov pubmed › 34118236

Decoding molnupiravir-induced mutagenesis in SARS-CoV-2

Molnupiravir, a prodrug of the nucleoside derivative β-D-N<sup>4</sup>-hydroxycytidine (NHC), is currently in clinical trials for COVID-19 therapy. However, the biochemical mechanisms involved in molnupiravir-induced mutagenesis had not...

ncbi.nlm.nih.gov pubmed › 34762722

Usefulness of lung ultrasound in the early identification of severe COVID-19: results from a prospective study

The combination of the ultrasound score and the presence of respiratory failure can easily identify patients with a higher risk to present complications.